MediFind found 5 doctor with experience in X-Linked Retinitis Pigmentosa (XLRP) near Toms River, NJ. Of these, 5 are Experienced.
Shore Eye Associates PA
Vipul Lakhani is an Ophthalmologist in Toms River, New Jersey. Dr. Lakhani is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). His top areas of expertise are Glaucoma, Cataract, Dry Eye Syndrome, and Late-Onset Retinal Degeneration. Dr. Lakhani is currently accepting new patients.
Shore Eye Associates PA
Harjit Athwal is an Ophthalmologist in Toms River, New Jersey. Dr. Athwal is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). His top areas of expertise are Presbyopia, Neurotrophic Keratitis, Eyelid Bump, and Glaucoma. Dr. Athwal is currently accepting new patients.
Shore Eye Associates PA
Jane Pan is an Ophthalmologist in Toms River, New Jersey. Dr. Pan is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). Her top areas of expertise are Blepharitis, Choroid Plexus Carcinoma, Cataract, and Age-Related Macular Degeneration (ARMD). Dr. Pan is currently accepting new patients.
Ocean Eye Institute PA
David Grossman is an Ophthalmologist in Toms River, New Jersey. Dr. Grossman is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). His top areas of expertise are Dry Eye Syndrome, Glaucoma, Cataract, and Age-Related Macular Degeneration (ARMD). Dr. Grossman is currently accepting new patients.
Ocean County Retina PC
Mohammedyusuf Hajee is an Ophthalmologist in Toms River, New Jersey. Dr. Hajee is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Choroid Plexus Carcinoma, and Kallikrein Hypertension.
To see more doctors, please expand your search radius or view related conditions below.
Last Updated: 10/30/2025